Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients-Reference-Cited by-同舟云学术

Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients

Published:2018-11-11 Issue:19 Volume: Page:106-112
ISSN:2079-701X
Container-title:Medical Council
language:
Short-container-title:Med. sov.

Author:

Vorobyev N. V.¹,Popov S. V.²

Affiliation:

1. Federal State Budgetary Institution National Medical Research Radiological Center of the Ministry of Health of Russia, Moscow

2. Medical Institute of the Russian Peoples’ Friendship University, Moscow

Abstract

Oncourologic diseases are accompanied by a risk for subsequent venous thromboembolic complications, which are rated the most dangerous in terms of thrombogenic effect. The article presents a review of the clinical studies of efficacy and safety, and the experience in using of modern low-molecular-weight heparins in clinical practice - drugs of choice for the prevention of venous thromboembolic complications in cancer patients. Particular attention is paid to Bemiparin - a new second-generation low-molecular-weight heparin with a significant antithrombotic effect and improved pharmacological parameters that allow it to be successfully used in patients with impaired renal function in oncourological practice.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Bokeria LA, Zatevakhin II, Kirienko AI et al. The Russian clinical guidelines for the diagnosis, treatment and prevention of venous thromboembolic complications (VTEC). Flebologiya, 2015, 9 (4), No. 2. 52 p.

2. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 2005, 293(6): 715-722.

3. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancerpatients undergoing chemotherapy in the United States. Cancer, 2013, 119(3): 648-655.

4. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost, 2006, 4(3): 529-535.

5. Chernyshev IV, Perepechin DV. Complex prophylaxis of thromboembolic complications in urological patients. Eksperimentalnaya i Klinicheskaya Urologiya, 2012, 1: 57-62.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MECHANISMS OF THROMBOTIC READINESS STATE FORMATION IN CARDIOLOGICAL PATIENTS WITH ACTIVE ONCOLOGICAL PROCESS;Vestnik of North-Eastern Federal University. Medical Sciences;2023-12-17